Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure
Heart failure is a leading cause of disability and death worldwide, affecting 1–2% of adults—and over 10% of people over 70. As the final stage of many cardiovascular diseases (CVDs), it occurs when the heart can’t pump enough blood to meet the body’s needs. Symptoms like shortness of breath, fatigue, and leg swelling can devastate quality of life, and even with treatment, 17% of hospitalized patients die within a year. But a growing body of research points to an unexpected player in heart failure: the gut microbiota—the trillions of bacteria, fungi, and viruses living in your intestines.
The Gut Microbiota: Your Body’s “Superorganism”
Your gut isn’t just a digestion tube—it’s a dynamic ecosystem. The gut microbiota contains 10 times more cells than your entire body and 100 times more genetic material than your genome. For a healthy person, two bacterial phyla dominate: Bacteroidetes and Firmicutes. These microbes do far more than break down food—they:
- Produce energy for gut cells.
- Regulate your immune system to prevent harmful inflammation.
- Make vitamins (like B12 and K) and other compounds that affect distant organs, including your heart.
In short, you and your gut bacteria act as a “superorganism,” working together to keep you healthy. When this balance is disrupted—called dysbiosis—it can trigger or worsen chronic diseases, including heart failure.
How Gut Dysbiosis Links to Heart Failure
Studies using advanced DNA sequencing (like 16S rRNA and metagenomics) reveal that people with heart failure have less diverse gut bacteria and fewer “good” bacteria that protect health. Key findings include:
- Depleted SCFA-producing bacteria: Short-chain fatty acids (SCFAs)—like butyrate and acetate—are made when bacteria ferment dietary fiber. They nourish gut cells, reduce inflammation, and support heart health. Heart failure patients have fewer bacteria from families like Lachnospiraceae and Ruminococcaceae, which produce these beneficial compounds. For example, Faecalibacterium prausnitzii (a major butyrate producer) is less abundant in older heart failure patients.
- More pathogenic bacteria: Chronic heart failure patients often have higher levels of harmful bacteria like Candida, Campylobacter, and Shigella in their stools—especially those with severe disease.
- Leaky gut syndrome: Heart failure reduces blood flow to the gut, causing intestinal cells to become starved of oxygen and nutrients. This makes the gut wall “leaky,” allowing bacteria and toxins (like lipopolysaccharides, or LPS) to leak into the bloodstream. These toxins trigger systemic inflammation, which worsens heart failure—a vicious cycle known as the gut hypothesis of heart failure.
Key Metabolic Pathways: How Gut Bacteria Affect Your Heart
Beyond direct bacterial translocation, gut microbes influence heart health through metabolic pathways—chemical reactions that produce compounds your body uses (or that harm it). Three pathways stand out:
1. The TMAO Pathway: A Marker of Poor Prognosis
Trimethylamine N-oxide (TMAO) is a compound made when gut bacteria break down choline (found in eggs, liver, and red meat) or L-carnitine (in red meat and dairy). Your liver converts the byproduct (trimethylamine, TMA) into TMAO.
Research shows that high TMAO levels are linked to worse heart failure outcomes:
- A study of 720 stable heart failure patients found that those with the highest TMAO levels were 3–4 times more likely to die within 5 years—even after adjusting for traditional risk factors (like B-type natriuretic peptide, a heart failure marker).
- In 972 acute heart failure patients, elevated TMAO predicted higher in-hospital mortality and readmission rates.
TMAO harms the heart by promoting inflammation, disrupting cholesterol metabolism, and worsening vascular damage.
2. SCFAs: The “Good” Metabolites
Short-chain fatty acids (SCFAs) are the opposite of TMAO—they’re cardioprotective. They:
- Reduce inflammation: Butyrate (a type of SCFA) helps make regulatory T cells (Tregs), which calm overactive immune responses.
- Protect the gut barrier: SCFAs keep the intestinal wall tight, preventing leaks.
- Support heart repair: After a heart attack, SCFAs help recruit immune cells that heal damaged tissue.
Heart failure patients have fewer SCFA-producing bacteria, which may explain why inflammation and gut leakiness are so common in the condition.
3. Bile Acids and Uremic Toxins
- Bile acids: Your liver makes primary bile acids to digest fat, but gut bacteria turn them into secondary bile acids. Heart failure patients have a higher ratio of secondary to primary bile acids—a marker linked to shorter survival.
- Uremic toxins: When kidney function declines (common in heart failure), gut bacteria break down urea into ammonia, which becomes toxins like indoxyl sulfate. These toxins stimulate heart muscle scarring (fibrosis), worsening heart failure.
Targeting the Gut for Heart Failure Treatment
The link between gut dysbiosis and heart failure has opened doors to novel therapies that focus on restoring microbial balance. Here’s what research shows:
1. Diet: The Simplest Intervention
Diet is one of the most powerful ways to shape your gut microbiota. Studies suggest:
- High-fiber diets: A diet rich in fruits, vegetables, and whole grains increases SCFA-producing bacteria. In mice with high blood pressure (a heart failure risk factor), fiber supplements reduced heart enlargement and improved function.
- DASH and Mediterranean diets: The DASH (Dietary Approaches to Stop Hypertension) diet—low in sodium, high in fruits, veggies, and lean protein—was linked to lower mortality in women with heart failure. The Mediterranean diet (rich in olive oil, nuts, and fish) showed a similar trend, though not statistically significant.
2. Probiotics: “Good” Bacteria for Heart Health
Probiotics are live bacteria that restore gut balance. Small studies show promise:
- Lactobacillus rhamnosus GR-1: In rats with post-heart attack heart failure, this probiotic reduced heart enlargement and improved function.
- Saccharomyces boulardii: A pilot trial of 20 heart failure patients found that taking this yeast probiotic for 3 months improved left ventricular ejection fraction (LVEF)—a key measure of heart pumping ability—and reduced left atrial size.
3. Antibiotics: A Double-Edged Sword
Antibiotics can kill harmful gut bacteria, but they also wipe out beneficial ones. A small study of 10 severe heart failure patients found that non-absorbable antibiotics (like polymyxin B/tobramycin) reduced gut toxins and inflammation—but effects faded once treatment stopped. Most experts caution against routine antibiotic use for heart failure.
4. Fecal Microbiota Transplantation (FMT): Still Experimental
FMT involves transferring fecal matter from a healthy donor to a patient to restore gut bacteria. It’s highly effective for C. difficile infections, but for heart failure, data is limited. Risks (like transferring harmful pathogens) and uncertainty about long-term effects mean FMT is not yet a standard treatment.
5. TMAO Inhibitors: A Promising New Frontier
Drugs that block TMA production (like 3,3-dimethyl-1-butanol, a choline analog) reduce TMAO levels and prevent atherosclerosis in mice. While no studies have tested these drugs in heart failure patients yet, they represent a exciting path for future research.
Conclusions and Future Directions
Heart failure remains a major health crisis, but the gut microbiota offers a new lens for understanding and treating it. Key takeaways from this review:
- Gut dysbiosis is a hallmark of heart failure: Patients have fewer SCFA-producing bacteria and more harmful microbes.
- Metabolites matter: TMAO, SCFAs, and bile acids link gut bacteria to heart health.
- Diet and probiotics show promise: Simple changes like eating more fiber or taking specific probiotics could improve heart failure outcomes—though larger human studies are needed.
But there’s still much to learn. Future research should:
- Explore how gut bacteria interact with heart failure medications (like beta-blockers or ACE inhibitors).
- Test TMAO inhibitors and “designer” probiotics in heart failure patients.
- Use large, long-term studies to confirm how diet and microbiota affect heart failure prognosis.
For now, the message is clear: Your gut and your heart are deeply connected. Taking care of your gut bacteria—through a healthy diet, limited antibiotic use, and possibly probiotics—could be a simple yet powerful way to support heart health.
doi.org/10.1097/CM9.0000000000000330
Was this helpful?
0 / 0